Skip to main content
search

Conference: JSSX 2025 in Japan

Date: October 20 - 23, 2025

Location: Kyoto, Japan

Join Certara at JSSX 2025 in Kyoto.

We’re excited to participate in JSSX 2025 in Kyoto, The 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics. Please feel free to stop by our booth to ask any questions about software and services. Japanese experts will be at Certara’s booth to answer your questions.

QSP: Predict clinical outcomes for novel targets, modalities & combinations

Quantitative Systems Pharmacology (QSP) consulting services at Certara combine computational modeling and experimental data to address complex challenges in drug development. QSP bridges the gap between biology and pharmacology by generating a quantitative math model to characterize therapeutic pharmacology in the context of a complex biological system, disease processes, and therapeutic mechanism of action (MOA). By examining interactions between drugs, biological systems, and diseases, QSP offers a robust framework for predicting clinical outcomes, optimizing therapeutic strategies, and streamlining decision-making. Certara’s regulatory-ready platforms support reproducible model development across various therapeutic areas, including oncology, inflammation and immunology, and neurodegenerative diseases.

Refining dosing strategies and enhancing risk assessment with Simcyp® PBPK Simulator

The Simcyp® PBPK Simulator predicts drug behavior within the human body, aiding in various stages of drug development. This includes determining optimal dosing for first-in-human trials, optimizing clinical study designs, evaluating new drug formulations, predicting drug-drug interactions, and conducting virtual bioequivalence analyses. At our booth, you can learn more details including key features below:

  • Extensive libraries on demographics, developmental physiology, and drug elimination pathways.
  • Advanced mechanistic organ models and compound files.
  • Integrates in vitro data with in vivo outcomes to support informed decision making.
  • Virtual population simulations reflect diverse demographics, ethnicities, and disease states.
  • Includes 29 population libraries and over 100 small and large molecule models.
  • Availability to support compound and population verification documents for regulatory submissions.

Where to hear Certara insights and expertise

Thursday, October 23
Symposium 11:
Modeling and Systems Pharmacology DIS
Special Feature on Current State-of-the-Art Research in Systems Pharmacology
SY11-3:
QSP modeling of ADCs: case studies using Kadcyla and Enhertu

Chairs: Tsuyoshi Minematsu and Shinichi Kijima
Kimiko McGirr, PhD, Associate Principal Scientist, Certara

Resources

Watch the short video of Simcyp PBPK Simulator

Meet us there

Pre-book a free, no-obligation meeting with our technical experts at the show. Simply provide a few details and we’ll come armed with the right resources to best advise you.